Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02906202 |
|---|---|
| Brief Title: | A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype |
| First Submitted : | August 19, 2016 |
| First Submitted that Met QC Criteria : | September 14, 2016 |
| First Posted : | September 20, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 25, 2022 |
| Last Update Posted : | April 27, 2022 |